Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China
- PMID: 29523451
- DOI: 10.1016/j.vaccine.2018.02.112
Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China
Abstract
Objective: To systematically investigate the prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B (NmB) in China.
Methods: A total of 485 NmB strains isolated in 29 provinces of China between 1968 and 2016 were selected from the culture collection of the national reference laboratory according to the isolation year, location, and source. Multi-locus sequence typing (MLST) and porA gene sequencing were performed on all 485 study strains; PCR was used to detect the fHbp, nadA, and nhba gene of 432 strains; positive amplification products from the fHbp and nadA genes from all strains, as well as those of the nhba gene from 172 representative strains, were sequenced.
Results: MLST results showed that the predominant (putative) clonal complexes (CCs) of NmB isolates have changed over time in China. While strains that could not be assigned to existing (p)CCs were the biggest proportion, CC4821 was the most prevalent lineage (36.0%) since 2005. PCR and sequence analysis revealed that the 4CMenB and rLP2086 vaccine candidates were highly diverse. Respectively, 152 PorA genotypes and 83 VR2 sequences were identified with significant diversity within a single CC; the complete nadA gene was found in ten of 432 study strains; fHbp was present in most strains (422/432) with variant 2 predominating (82.9%) in both patient- and carrier- derived isolates; almost all strains harbored the nhba gene while sequences were diverse.
Conclusions: With regards to clonal lineages and vaccine candidate proteins, NmB isolates from China were generally diverse. Further studies should be performed to evaluate the cross-protection of present vaccines against Chinese NmB strains.
Keywords: China; Clonal complex; Neisseria meningitidis serogroup B; Vaccine candidate.
Copyright © 2018. Published by Elsevier Ltd.
Similar articles
-
Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.Hum Vaccin Immunother. 2024 Dec 31;20(1):2378537. doi: 10.1080/21645515.2024.2378537. Epub 2024 Jul 22. Hum Vaccin Immunother. 2024. PMID: 39037011 Free PMC article.
-
[Molecular characteristics of serogroup B neisseria meningitidis, China].Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Feb 6;53(2):153-158. doi: 10.3760/cma.j.issn.0253-9624.2019.02.006. Zhonghua Yu Fang Yi Xue Za Zhi. 2019. PMID: 30744288 Chinese.
-
Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.BMC Microbiol. 2014 Apr 29;14:111. doi: 10.1186/1471-2180-14-111. BMC Microbiol. 2014. PMID: 24779381 Free PMC article.
-
Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups.Hum Vaccin Immunother. 2024 Dec 31;20(1):2409502. doi: 10.1080/21645515.2024.2409502. Epub 2024 Oct 10. Hum Vaccin Immunother. 2024. PMID: 39387286 Free PMC article. Review.
-
MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine.Vaccine. 2015 May 28;33(23):2629-36. doi: 10.1016/j.vaccine.2015.04.015. Epub 2015 Apr 13. Vaccine. 2015. PMID: 25882169 Review.
Cited by
-
Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020.mSphere. 2024 Jun 25;9(6):e0022024. doi: 10.1128/msphere.00220-24. Epub 2024 May 16. mSphere. 2024. PMID: 38752729 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical